Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 25-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 17)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
27-May-13 Alpha Street Research Hunter Orr OPTR - Optimer Pharmaceuticals Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report 9 $24 View Abstract
24-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
24-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: FOLD , CNDO , HALO , OPTR , OREX , GEVA , VNDA -- DRUGS 3 $34.50 View Abstract
23-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for OPTR 11 $126.50 View Abstract
20-May-13 Pechala's Reports Lubomir Pechala OPTIMER PHARMACEUTICALS INC (OPTR) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
20-May-13 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala OPTIMER PHARMACEUTICALS INC (OPTR) 12-months forecast 1 $15 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Value Graph: OPTIMER PHARMACE -- OPTR 1 $11.50 View Abstract
16-May-13 S&P Capital IQ Quantitative Report N/A Optimer Pharmaceuticals 6 $69 View Abstract
13-May-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Optimer Pharmaceuticals Inc 40 $460 View Abstract
Next 7

Independent Reports (Showing 1 to 10 of 17)

Release
Date Contributor Author Title Pages Price More Info
27-May-13 Alpha Street Research Hunter Orr OPTR - Optimer Pharmaceuticals Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report 9 $24 View Abstract
24-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
24-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: FOLD , CNDO , HALO , OPTR , OREX , GEVA , VNDA -- DRUGS 3 $34.50 View Abstract
23-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for OPTR 11 $126.50 View Abstract
20-May-13 Pechala's Reports Lubomir Pechala OPTIMER PHARMACEUTICALS INC (OPTR) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
20-May-13 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala OPTIMER PHARMACEUTICALS INC (OPTR) 12-months forecast 1 $15 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Value Graph: OPTIMER PHARMACE -- OPTR 1 $11.50 View Abstract
16-May-13 S&P Capital IQ Quantitative Report N/A Optimer Pharmaceuticals 6 $69 View Abstract
13-May-13 Wright Reports N/A Wright Investors Service Comprehensive Report for Optimer Pharmaceuticals Inc 40 $460 View Abstract
Next 7

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.